NCT05202873

Brief Summary

The main objective of the study is to evaluate spatiotemporal parameters of gait in tumoral patients with megaprosthesis of the distal femur.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2018

Completed
3.9 years until next milestone

First Submitted

Initial submission to the registry

January 10, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 24, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

6.7 years

First QC Date

January 10, 2022

Last Update Submit

December 6, 2024

Conditions

Keywords

Gait AnalysisCase-control studyMegaprosthesisOrthopedic oncologyMusculoskeletal tumourDistal femurInertial Measurement Unit

Outcome Measures

Primary Outcomes (13)

  • Antero-posterior acceleration symmetry index

    This metric serves as a quantifiable measure of the symmetry exhibited in movements along the antero-posterior axis, thereby illustrating the equilibrium and coordination inherent in the body's kinetic activities.

    3 months

  • Stance Phase

    Refers to the portion of the gait cycle during which a foot is in contact with the ground. It begins with the initial contact (heel strike) and ends when the same foot leaves the ground (toe-off). The stance phase is a critical component of walking and running, contributing to balance, propulsion, and weight-bearing. Measured as a percentage of the total gait cycle, 60% of the cycle in typical walking.

    3 months

  • Swing Phase

    Refers to the portion of the gait cycle during which a foot is not in contact with the ground. It begins when the foot lifts off the ground (toe-off) and ends when the same foot makes contact again (heel strike). The swing phase allows the leg to advance forward and position itself for the next step. Measured as a percentage of the total gait cycle, 40% of the cycle in normal walking.

    3 months

  • Gait Quality Index

    The stance-swing phase ratio

    3 months

  • First Double support phase

    Refers to the portion of the gait cycle during walking when both feet are in contact with the ground simultaneously. It occurs at the beginning of the stance phase for one leg, immediately after heel strike, and ends when the opposite foot lifts off (toe-off). This phase contributes to stability during gait. Measured as a percentage of the total gait cycle.

    3 months

  • Single Support Phase

    Refers to the portion of the gait cycle during which only one foot is in contact with the ground bearing the entire body weight while the other foot is in the swing phase. It is essential for maintaining balance and forward progression during walking. Measured as a percentage of the total gait cycle.

    3 months

  • Propulsion Index

    This measures the subject's ability to propel the centre of mass forward during the single support stance phase.

    3 months

  • Pelvic tilt range

    Refers to the total angular movement of the pelvis in the sagittal plane during a specific activity, such as walking. It represents the difference between the maximum anterior tilt (forward rotation) and maximum posterior tilt (backward rotation) of the pelvis within a given cycle. Measured in degrees (°) to quantify the extent of pelvic rotation.

    3 months

  • Pelvic obliquity range

    Refers to the total angular movement of the pelvis in the coronal (frontal) plane during activities such as walking. It describes the difference between the maximum upward tilt (hip hike) and maximum downward tilt (hip drop) of one side of the pelvis relative to the opposite side. Measured in degrees (°) to quantify the range of motion.

    3 months

  • Pelvic rotation range

    Refers to the total angular movement of the pelvis in the transverse (horizontal) plane during activities such as walking. It represents the difference between the maximum forward rotation and maximum backward rotation of the pelvis around a vertical axis within a given cycle. Measured in degrees (°) to quantify the range of rotational motion.

    3 months

  • Pelvic symmetry tilt index

    Is a quantitative measure that evaluates the symmetry of pelvic tilt during movement. It assesses the degree of deviation in pelvic tilt between the left and right sides in the sagittal plane, providing insight into potential imbalances or asymmetries. Expressed as a percentage (%) to indicate the level of symmetry.

    3 months

  • Pelvic symmetry obliquity index

    Is a quantitative measure used to evaluate the symmetry of pelvic obliquity during movement. It quantifies the degree of deviation in upward or downward tilt of the pelvis on one side compared to the other in the coronal (frontal) plane, helping to identify potential imbalances or asymmetries. Expressed as a percentage (%) to represent the level of symmetry.

    3 months

  • Pelvic symmetry rotation index

    Is a quantitative measure used to assess the symmetry of pelvic rotation during movement, particularly in the transverse (horizontal) plane. It calculates the difference in rotational movement between the left and right sides of the pelvis, helping to identify any imbalances or asymmetries in pelvic motion during activities like walking.Expressed as a percentage (%) to indicate the level of symmetry.

    3 months

Secondary Outcomes (2)

  • Bone remmant (%)

    3 months

  • Long discrepancy (mm)

    3 months

Study Arms (2)

Cases

Patients with distal femoral megaprosthesis due to musculoskeletal tumor

Diagnostic Test: Gait analysis

Control

Healthy subjects

Diagnostic Test: Gait analysis

Interventions

Gait analysisDIAGNOSTIC_TEST

Gait assessment will be performed using a non-invasive device. It is the BTS G-sensor inertial sensor (BTS Bioengineering, Garbagnate Milanese, Italy). The spatiotemporal variables of gait will be studied from the Walk+ protocol, in which the participant navigates a 7-meter hallway six times, completing three round trips with necessary turns at each end to change direction.

CasesControl

Eligibility Criteria

Age16 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent a megaprosthesis of the lower limb (distal femur) at Hospital La Fe by the orthopedic surgery and traumatology service, due to a tumor cause

You may qualify if:

  • Megaprosthesis of the distal femur
  • Tumor cause
  • Surgery at Hospital la Fe.
  • Traditional stem or biological ossteointegration system
  • Minimum postoperative follow-up period of 3 months

You may not qualify if:

  • Neurological alterations prior to the intervention that affect the lower limbs or general movement.
  • Patient incapable of ambulation due to progression of his/her pathology
  • Patient at home with palliative treatment for advanced tumor disease
  • Any ipsilateral or contralateral prosthesis.
  • Infectious or traumatic cause

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Ceu Cardenal Herrera

Valencia, 46006, Spain

Location

Related Publications (2)

  • Wilson PJ, Steadman P, Beckman EM, Connick MJ, Carty CP, Tweedy SM. Fitness, Function, and Exercise Training Responses after Limb Salvage With a Lower Limb Megaprosthesis: A Systematic Review. PM R. 2019 May;11(5):533-547. doi: 10.1002/pmrj.12045. Epub 2019 Mar 7.

    PMID: 30844129BACKGROUND
  • Morri M, Forni C, Ruisi R, Giamboi T, Giacomella F, Donati DM, Benedetti MG. Postoperative function recovery in patients with endoprosthetic knee replacement for bone tumour: an observational study. BMC Musculoskelet Disord. 2018 Oct 2;19(1):353. doi: 10.1186/s12891-018-2280-7.

    PMID: 30285683BACKGROUND

MeSH Terms

Interventions

Gait Analysis

Intervention Hierarchy (Ancestors)

GaitPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisPhysical Functional PerformancePhysical FitnessHealthPopulation Characteristics

Study Officials

  • JUAN FRANCISCO LISÓN, PhD

    Cardenal Herrera University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of the Deparment of Biomedical Sciences

Study Record Dates

First Submitted

January 10, 2022

First Posted

January 24, 2022

Study Start

February 8, 2018

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations